Lyra Therapeutics (LYRA) Cash from Operations (2019 - 2025)

Quarterly Cash from Operations rose 46.56% to 6066000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 28859000.0 through Dec 2025, up 58.78% year-over-year, with the annual reading at 28859000.0 for FY2025, 58.78% up from the prior year.

Lyra Therapeutics' Cash from Operations history spans 7 years, with the latest figure at 6066000.0 for Q4 2025.

  • Cash from Operations came in at 6066000.0 for Q4 2025, up from 7361000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3381000.0 in Q2 2021 to a low of 22455000.0 in Q1 2024.
  • The 5-year median for Cash from Operations is 11324500.0 (2021), against an average of 11568950.0.
  • Year-over-year, Cash from Operations surged 145.21% in 2021 and then crashed 350.52% in 2022.
  • Lyra Therapeutics' Cash from Operations stood at 11297000.0 in 2021, then dropped by 7.67% to 12164000.0 in 2022, then plummeted by 56.68% to 19058000.0 in 2023, then surged by 40.43% to 11352000.0 in 2024, then surged by 46.56% to 6066000.0 in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Cash from Operations are 6066000.0 (Q4 2025), 7361000.0 (Q3 2025), and 6590000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.67 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.43 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.08 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 70.50 Mn
10 Lyra Therapeutics - - - -6.07 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -6.07 Mn
Dec 31, 2025 -6.07 Mn
Sep 30, 2025 -7.36 Mn
Sep 30, 2025 -7.36 Mn
Jun 30, 2025 -6.59 Mn
Jun 30, 2025 -6.59 Mn
Mar 31, 2025 -8.84 Mn
Mar 31, 2025 -8.84 Mn
Dec 31, 2024 -11.35 Mn
Dec 31, 2024 -11.35 Mn
Sep 30, 2024 -16.22 Mn
Sep 30, 2024 -16.22 Mn
Jun 30, 2024 -19.98 Mn
Jun 30, 2024 -19.98 Mn
Mar 31, 2024 -22.46 Mn
Mar 31, 2024 -22.46 Mn
Dec 31, 2023 -19.06 Mn
Dec 31, 2023 -19.06 Mn
Sep 30, 2023 -14.11 Mn
Sep 30, 2023 -14.11 Mn
Jun 30, 2023 -14.28 Mn
Jun 30, 2023 -14.28 Mn
Mar 31, 2023 -15.85 Mn
Mar 31, 2023 -15.85 Mn
Dec 31, 2022 -12.16 Mn
Dec 31, 2022 -12.16 Mn
Sep 30, 2022 -10.85 Mn
Sep 30, 2022 -10.85 Mn
Jun 30, 2022 -8.47 Mn
Jun 30, 2022 -8.47 Mn
Mar 31, 2022 -11.91 Mn
Mar 31, 2022 -11.91 Mn
Dec 31, 2021 -11.30 Mn
Dec 31, 2021 -11.30 Mn
Sep 30, 2021 -10.31 Mn
Sep 30, 2021 -10.31 Mn
Jun 30, 2021 3.38 Mn
Jun 30, 2021 3.38 Mn
Mar 31, 2021 -7.59 Mn
Mar 31, 2021 -7.59 Mn
Dec 31, 2020 -5.87 Mn
Dec 31, 2020 -5.87 Mn
Sep 30, 2020 -3.78 Mn
Sep 30, 2020 -3.78 Mn
Jun 30, 2020 -7.48 Mn
Jun 30, 2020 -7.48 Mn
Mar 31, 2020 -4.02 Mn
Mar 31, 2020 -4.02 Mn
Dec 31, 2019 -3.92 Mn
Dec 31, 2019 -3.92 Mn
Sep 30, 2019 -3.83 Mn
Sep 30, 2019 -3.83 Mn
Jun 30, 2019 -3.00 Mn
Jun 30, 2019 -3.00 Mn
Mar 31, 2019 -3.01 Mn
Mar 31, 2019 -3.01 Mn